Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.089 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |